Lenzing's Biobased Wipe Clinches Award as Stock Surges 48% from March Trough
19.06.2026 - 05:57:22 | boerse-global.de
A cleaning wipe made entirely from regenerated cellulose has handed Lenzing an unexpected catalyst on the international stage. The Austrian fiber producer won the INDEX™ 26 Award at the Geneva trade fair for its DualWipe nonwoven material, which combines an abrasive side with a soft, absorbent surface while eliminating synthetic fibers, binders, and finishing chemicals. The absence of microplastics aligns directly with what European regulators are demanding — and investors have taken notice.
The stock has been on a tear. Since hitting a low in March, Lenzing shares have climbed 48.20%, with a blistering 22.08% gain in the past seven trading days alone. On Thursday, the equity touched a fresh 52-week high of €29.10. Just days earlier it had been trading at €28.85, a mere 0.86% below the previous high set on June 18. Year-to-date, the advance stands at roughly 20%, while over twelve months the increase is 32%.
Behind the rally lies more than a single award. Lenzing has been showcasing its cellulose-based fibers at major trade shows across three continents this year — the CIDPEX in Nanjing, Techtextil in Frankfurt, and now the INDEX in Geneva — positioning its technology as a scalable replacement for fossil-derived materials. Europe's push to reduce plastic dependency and strengthen economic sovereignty is creating a tailwind for the company's biobased offerings, and customers are scrambling to green their supply chains.
Should investors sell immediately? Or is it worth buying Lenzing?
That said, the stock's breakneck ascent has pushed it deep into overbought territory. The relative strength index stands at 79, well above the threshold that typically signals exhaustion. The 200-day moving average, which the stock only breached in mid-June, currently sits at €24.17 — a full 17% below the current price.
The recent euphoria masks a painful restructuring. Lenzing posted a net loss of €135.2 million last year, its fourth consecutive annual loss. Management responded with a harsh cost-cutting program that has already delivered savings in the triple-digit million range. The elimination of roughly 300 positions at the company's headquarters will generate €25 million annually starting next year, with additional efficiency gains targeted through 2027. Operating profit inched up to €413.0 million, lifting the margin to 15.9%. One lingering uncertainty: the search for a new chief executive following Rohit Aggarwal's departure in January.
The strategic pivot is clear. Synthetic fibers are losing ground, biobased alternatives are gaining. Lenzing's market capitalization has climbed to around €1 billion, raising the question of whether the sector's structural shift still offers valuation upside. For a front-runner in this transition, the argument goes, the current multiple may be justified.
Risks, however, remain. The Iran conflict is pushing up energy and chemical costs, eating into the efficiency gains management has worked so hard to secure. The company's cellulose fibers may be winning prizes at trade shows across Europe, but the final verdict on whether the share price deserves another encore will come with the next quarterly results.
Ad
Lenzing Stock: New Analysis - 19 June
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
